Brind.

Nektar Therapeutics noted a potential benefit from Trump-era tariffs and onshoring policies.

1 report, 0 independent Updated Jul 6

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Nektar Therapeutics Donald Trump

Keep exploring

The entities involved

Nektar Therapeutics
American healthcare company
- Nektar Therapeutics' board granted stock options to new employees on October 23, 2026.Fri 22:38
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
- Abdul El-Sayed won the Michigan Senate primary and is now facing political challenges, including criticism from Donald Trump and discussions about potential support from Barack Obama.Sun 23:57
- Trump, Hegseth, and Bessent discuss threats and escalation against Iranian targets in the Strait of Hormuz.Sun 23:56

Coverage

Newest first; wire copies grouped

Jul 6Unknown outlet